In this issue
From the perspective of their clinical and holistic role, and restriction of access to means, there are opportunities to involve pharmacy teams in suicide prevention. This article examines the published evidence-base and the success of ongoing programmes and initiatives in the United States and Canada to produce a set of recommendations for the benefit of UK practice on the opportunities community pharmacy teams have to raise awareness and help prevent suicide and self-harm.
A pain-free 1–10 minute breath sampler could enhance and speed up the early detection of a range of cancers, writes Balkees Abderrahman.
Managing the symptoms of overactive bladderSubscription
Overactive bladder can be distressing and embarrassing. Understanding the symptoms, diagnosis and evidence-based management can significantly improve quality of life.
Study shows needle and syringe programmes reduce transmission of hepatitis C while delivering cost savings.
Initial concerns that finasteride could increase risk of prostate cancer death have been found to be unwarranted in a long-term follow-up study.
The opioid antagonist naltrexone does not appear to increase the risk of serious adverse events over placebo, researchers from the University of Manchester have found.
A previously identified link between antidepressant use and hip fractures needs further examination, the authors of a study published in JAMA Psychiatry have concluded.
Impact of opioid prescribing following arthroplasty on long-term opioid prescribing in the communitySubscription
Adequate relief of acute postsurgical pain is a metric of patient satisfaction. Patients undergoing hip and knee arthroplasty — in which joints are altered or replaced — ...
Medication errors that lead to adverse drug events are a major problem, and one that has been acknowledged by the World Health Organization’s third Global Patient Safety Challenge. In the UK,